Category Archives for: NASDAQ:IBB
Visit our full IBB ticker page for ratings, quotes, and much more »

An ETF to keep on radar after biotech stocks beat earnings estimates

business graphic
From Sweta Jaiswal : President Trump’s latest move to raise the tariffs to 25% from 10% on $200 billion of Chinese goods might have ‘trumped’ hopes of many investors waiting for a truce between the two largest economies. However, amid…
Read more ›
NASDAQ:IBB May 8, 2019 3:10pm

Will the rally in the Biotech sector continue?

biotech sector
From Keris Lahiff: Biotech is blazing higher.
NASDAQ:IBB March 4, 2019 12:54pm

Analysts predict more inflows to Biotech ETFs

biotech stock
From ETF Trends: This article was originally published on ETFTrends.com.
NASDAQ:IBB February 13, 2019 1:56pm

Why Biotech ETFs Are Rallying in 2019

etf
From Sanghamitra Saha: This year, biotech stocks have seen their best-ever start to a year since 2012. A solid merger-and-acquisition momentum has been instrumental in this rally. The announcement of the mega-merger deal between Bristol-Myers (BMY – Free Report) and Celgene CELG at the beginning of 2019 has set…
Read more ›
NASDAQ:IBB January 24, 2019 5:13pm

Biotech stocks are off to the best start of the year since 2012

Biotechnology Sector
From Bertha Coombs: After brutal losses to end 2018, the biotech sector is off to the best start of the year since 2012.
NASDAQ:IBB January 11, 2019 11:59am

iShares Nasdaq Biotechnology ETF (IBB) Experiences Big Inflow

Biotechnology Sector
From ETF Channel: Exchange traded funds (ETFs) trade just like stocks, but instead of ”shares” investors are actually buying and selling ”units”. These ”units” can be traded back and forth just like stocks, but can also be created or destroyed…
Read more ›
NASDAQ:IBB December 10, 2018 1:31pm

Here’s What’s Pushing Biotech Further Than Ever Before

From Franklin Templeton Investments: Franklin Equity Group’s Evan McCulloch explains why higher rates of drug utilization and health care spending are lending support to the biotechnology and health care industries. He also gives his take on recent medical breakthroughs he…
Read more ›
NASDAQ:IBB September 26, 2018 6:11am

Biotech ETFs Are Back In Vogue (IBB)

From Zacks: The biotech sector has been performing remarkably well driven by a wave of mergers & acquisitions, new tax legislation, and a positive regulatory backdrop.
NASDAQ:IBB August 13, 2018 6:14am

Biotech Presents Another Interesting Opportunity (IBB)

From Contrarian Outlook: Today I want to show you a beaten-down sector that has a long history of crushing the market–and 4 funds that should be on your radar now.
NASDAQ:IBB April 20, 2018 6:39am

What’s The Best Biotech ETF To Buy Right Now? (IBB)

From Zacks: The biotech sector has been attracting a lot of investor attention lately. This sector is expected to continue benefiting from increased M&A activities, new drug approvals, better R&D and innovations.
NASDAQ:IBB March 2, 2018 6:03am

Biotech Is Back In A Major Way (IBB)

From Dana Lyons: Left for dead after a bubbly blowoff in 2015, biotech stocks have finally clawed their way back to new highs.
NASDAQ:IBB January 13, 2018 5:04am

Can Biotech ETFs Continue Their Impressive Run In 2018? (IBB)

From Zacks: So far, it’s been a good year for biotech stocks with the Nasdaq Biotechnology Index soaring 19.6% year to date.
NASDAQ:IBB November 14, 2017 7:09am

Outflows Start To Hit The iShares NASDAQ Biotech ETF (IBB)

Analyst/ETF Trader Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today examines a relatively muted ETF landscape that’s seen smallish outflows in biotech and some renewed interest in volatility products ahead of earnings season.
NASDAQ:IBB October 24, 2017 11:46am

Biotech Was The Hottest ETF Sector In The Third Quarter (IBB)

From Zacks: The broader market was pretty eventful in the third quarter. While geopolitical and political concerns were rife, those threats couldn’t weigh on the equity market returns.
NASDAQ:IBB October 3, 2017 10:09am

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

From Our Partners

9 'MUST OWN' Growth Stocks for 2021

Most Popular

Our Exclusive Tools

Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories